Bradley C. Martin
High Impact
Professor
faculty
Pharmacy Practice, College of Pharmacy
50 h-index
255 pubs
11,818 cited
Research Areas
Biography and Research Information
OverviewAI-generated summary
Bradley C. Martin's research primarily focuses on the outcomes and utilization of healthcare services, with a significant emphasis on opioid use and its associated factors. He has investigated trajectories of opioid coverage for veterans on long-term therapy and the association between discontinuing chronic opioid therapy and the development of substance use disorders, accidents, and drug overdoses.
His work also extends to cancer treatment outcomes, including a retrospective study on the real-world survival of first-line immune checkpoint inhibitor treatment versus chemotherapy in older patients with non–small-cell lung cancer and synchronous brain metastases. Additionally, Dr. Martin has examined adherence to extended venous thromboembolism prophylaxis after gastrointestinal oncologic surgery and explored data science approaches to improve outcomes for individuals with opioid use disorder. He has also contributed to understanding perceptions of HPV vaccination and pharmacist-physician collaboration.
Dr. Martin holds an h-index of 50 with over 11,800 citations across 259 publications. He leads a research group and maintains an active lab website. His key collaborators at the University of Arkansas for Medical Sciences include Corey J. Hayes, Chenghui Li, Jacob T. Painter, and Mahip Acharya, with whom he has co-authored multiple publications.
Metrics
- h-index: 50
- Publications: 255
- Citations: 11,818
Selected Publications
-
Rural–Urban Differences in Use of Diabetes Self-Management Education and Support in Arkansas, 2015–2019 (2026)
-
Venous thromboembolism diagnosis definition in claims data: implications for research (2025)
-
Disparities in Extended Venous Thromboembolism Prophylaxis After Pancreatic Cancer Surgery (2025)
-
Clinical outcomes of extended venous thromboembolism prophylaxis after oncologic colorectal surgery (2025)
-
An updated view on the influence of initial opioid prescription characteristics on long-term opioid use among opioid naïve patients (2024)
-
The role of prescribed controlled substance acquisition as potential triggers of opioid overdose: A case-crossover study (2024)
-
A Statewide Examination of Medical Cannabis Purchasing Patterns in Arkansas Over the Three Years Immediately Following Legalization (2024)
-
Average Daily Dose Trajectories for Episodes of Buprenorphine Treatment for Opioid Use Disorder. (2024)
-
Are gaps in rates of retention on buprenorphine for treatment of opioid use disorder closing among veterans across different races and ethnicities? A retrospective cohort study (2024)
-
Immune checkpoint inhibitors as subsequent treatment in older adults with non-small cell lung cancer and synchronous brain metastases (2024)
-
Development and validation of machine-learning algorithms predicting retention, overdoses, and all-cause mortality among US military veterans treated with buprenorphine for opioid use disorder (2024)
-
In-Hospital Mortality by Race and Ethnicity Among Hospitalized COVID-19 Patients Using Data From the US National COVID Cohort Collaborative (2024)
-
Opioid therapy trajectories of patients with chronic non-cancer pain over 1 year of follow-up after initiation of short-acting opioid formulations (2024)
-
The association between suspected long–COVID and stimulant prescribing in the United States (2023)
-
Clinical Observation, Management and Function Of low back pain Relief Therapies (COMFORT): A cluster randomised controlled trial protocol (2023)
Grants & Funding
- Impact of Opioid Dosing Strategies on Pain Scores and Adverse or Unintended Clinical Outcomes NIH Co-Investigator
- The influence of post-partum coverage extension on maternal depression screening NIH/Nat. Inst. of Child Health & Human Development - Pass Through: Tulane University Principal Investigator
- Arkansas Consortium for Health Services Research NIH Principal Investigator
- Prescribers, Pharmacists, and the Opioid Dilemma NIH/Nat. Inst. on Drug Abuse - Pass Through: RTI, International Co-Investigator
- Use and Abuse of Prescription Opioids Among OEF/OIF Veterans NIH Co-Investigator
- Early Care Decisions and the Risk of Long-Term Opioid Use in Patients with Low Back Pain UAMS Intramural Grant (CTSA) Principal Investigator
- ADVANCING RISK ADJUSTMENT FOR SCHIZOPHRENIA NIH Principal Investigator
- Utilization Patterns and Persistence of Antihormonal Therapies for Breast Cancer NOVARTIS Pharmaceuticals Corporation Principal Investigator
Collaboration Network
Top Collaborators
Corey J. Hayes
University of Arkansas for Medical Sciences
15 shared publications
In database
- Trajectories of Opioid Coverage After Long-Term Opioid Therapy Initiation Among a National Cohort of US Veterans
- Using Data Science to Improve Outcomes for Persons with Opioid use Disorder
- Association between discontinuing chronic opioid therapy and newly diagnosed substance use disorders, accidents, self‐inflicted injuries and drug overdoses within the prescribers' health care system: a retrospective cohort study
- Comparative Study of Opioid Initiation With Tramadol, Short-acting Hydrocodone, or Short-acting Oxycodone on Opioid-related Adverse Outcomes Among Chronic Noncancer Pain Patients
- Association between opioid therapy trajectories and potential opioid‐related adverse health events
Showing 5 of 15 shared publications
Chenghui Li
University of Arkansas for Medical Sciences
12 shared publications
In database
- Real-World Survival of First-Line Immune Checkpoint Inhibitor Treatment Versus Chemotherapy in Older Patients With Non–Small-Cell Lung Cancer and Synchronous Brain Metastases
- Association between discontinuing chronic opioid therapy and newly diagnosed substance use disorders, accidents, self‐inflicted injuries and drug overdoses within the prescribers' health care system: a retrospective cohort study
- The use of gabapentinoids and opioids and risk of developing opioid-induced respiratory depression among older breast cancer survivors with neuropathic pain
- Comparative Study of Opioid Initiation With Tramadol, Short-acting Hydrocodone, or Short-acting Oxycodone on Opioid-related Adverse Outcomes Among Chronic Noncancer Pain Patients
- Impact of transitioning from long-term to intermittent opioid therapy on the development of opioid-related adverse outcomes: A retrospective cohort study
Showing 5 of 12 shared publications
Jacob T. Painter
University of Arkansas for Medical Sciences
9 shared publications
In database
- Real-World Survival of First-Line Immune Checkpoint Inhibitor Treatment Versus Chemotherapy in Older Patients With Non–Small-Cell Lung Cancer and Synchronous Brain Metastases
- The use of gabapentinoids and opioids and risk of developing opioid-induced respiratory depression among older breast cancer survivors with neuropathic pain
- Comparative Study of Opioid Initiation With Tramadol, Short-acting Hydrocodone, or Short-acting Oxycodone on Opioid-related Adverse Outcomes Among Chronic Noncancer Pain Patients
- Factors Associated With Guideline-Concordant Pharmacological Treatment for Neuropathic Pain Among Breast Cancer Survivors
- Healthcare costs and utilization associated with pain among breast cancer survivors: a propensity score matched cohort study using SEER-Medicare data
Showing 5 of 9 shared publications
Mahip Acharya
University of Arkansas for Medical Sciences
8 shared publications
In database
- Associations Between Early Chiropractic Care and Physical Therapy on Subsequent Opioid Use Among Persons With Low Back Pain in Arkansas
- Comparative Study of Opioid Initiation With Tramadol, Short-acting Hydrocodone, or Short-acting Oxycodone on Opioid-related Adverse Outcomes Among Chronic Noncancer Pain Patients
- Opioid therapy trajectories of patients with chronic non-cancer pain over 1 year of follow-up after initiation of short-acting opioid formulations
- Development of a potential opioid misuse measure from administrative dispensing data and contrasting opioid misuse among individuals on long-term tramadol, long-term short-acting hydrocodone or long-term short-acting oxycodone therapy in Arkansas
- Evaluating the temporal association between the recency of prescribed controlled substance acquisition and fatal and non-fatal opioid overdose
Showing 5 of 8 shared publications
Teresa J. Hudson
Central Arkansas Veterans Healthcare System (US)
8 shared publications
- Association between discontinuing chronic opioid therapy and newly diagnosed substance use disorders, accidents, self‐inflicted injuries and drug overdoses within the prescribers' health care system: a retrospective cohort study
- Impact of transitioning from long-term to intermittent opioid therapy on the development of opioid-related adverse outcomes: A retrospective cohort study
- Association Between Pain Intensity and Discontinuing Opioid Therapy or Transitioning to Intermittent Opioid Therapy After Initial Long-Term Opioid Therapy: A Retrospective Cohort Study
- Evaluating the temporal association between the recency of prescribed controlled substance acquisition and fatal and non-fatal opioid overdose
- Average Daily Dose Trajectories for Episodes of Buprenorphine Treatment for Opioid Use Disorder.
Showing 5 of 8 shared publications
Lindsey Dayer
University of Arkansas for Medical Sciences (US)
7 shared publications
- The use of gabapentinoids and opioids and risk of developing opioid-induced respiratory depression among older breast cancer survivors with neuropathic pain
- Comparative Study of Opioid Initiation With Tramadol, Short-acting Hydrocodone, or Short-acting Oxycodone on Opioid-related Adverse Outcomes Among Chronic Noncancer Pain Patients
- Factors Associated With Guideline-Concordant Pharmacological Treatment for Neuropathic Pain Among Breast Cancer Survivors
- Healthcare costs and utilization associated with pain among breast cancer survivors: a propensity score matched cohort study using SEER-Medicare data
- Opioid therapy trajectories of patients with chronic non-cancer pain over 1 year of follow-up after initiation of short-acting opioid formulations
Showing 5 of 7 shared publications
Michail N. Mavros
6 shared publications
- Adherence to Extended Venous Thromboembolism Prophylaxis and Outcomes After Complex Gastrointestinal Oncologic Surgery
- Clinical outcomes of extended venous thromboembolism prophylaxis after oncologic colorectal surgery
- Disparities in Extended Venous Thromboembolism Prophylaxis After Pancreatic Cancer Surgery
- Venous thromboembolism diagnosis definition in claims data: implications for research
- ASO Visual Abstract: Adherence to and Outcomes of Extended Venous Thromboembolism Prophylaxis After Complex Gastrointestinal Oncologic Surgery
Showing 5 of 6 shared publications
Mario Schootman
Winthrop Rockefeller Foundation
6 shared publications
In database
- Adherence to Extended Venous Thromboembolism Prophylaxis and Outcomes After Complex Gastrointestinal Oncologic Surgery
- Clinical outcomes of extended venous thromboembolism prophylaxis after oncologic colorectal surgery
- Disparities in Extended Venous Thromboembolism Prophylaxis After Pancreatic Cancer Surgery
- Venous thromboembolism diagnosis definition in claims data: implications for research
- ASO Visual Abstract: Adherence to and Outcomes of Extended Venous Thromboembolism Prophylaxis After Complex Gastrointestinal Oncologic Surgery
Showing 5 of 6 shared publications
Austin Porter
Arkansas Department of Health
4 shared publications
In database
- Evaluating the temporal association between the recency of prescribed controlled substance acquisition and fatal and non-fatal opioid overdose
- The role of prescribed controlled substance acquisition as potential triggers of opioid overdose: A case-crossover study
- PDG39 Evaluating the Temporal Association between the Recency of Prescribed Controlled Substance Acquisition and Fatal and Non-Fatal Opioid Overdose
- EPH37 The Role of Prescribed Controlled Substance Acquisition As Potential Triggers of Opioid Overdose: A Case-Crossover Study
Michael A. Cucciare
University of Arkansas for Medical Sciences
4 shared publications
In database
- Using Data Science to Improve Outcomes for Persons with Opioid use Disorder
- Average Daily Dose Trajectories for Episodes of Buprenorphine Treatment for Opioid Use Disorder.
- Development and validation of machine-learning algorithms predicting retention, overdoses, and all-cause mortality among US military veterans treated with buprenorphine for opioid use disorder
- Are gaps in rates of retention on buprenorphine for treatment of opioid use disorder closing among veterans across different races and ethnicities? A retrospective cohort study
Adam J. Gordon
VA Salt Lake City Healthcare System (US)
4 shared publications
- Using Data Science to Improve Outcomes for Persons with Opioid use Disorder
- Average Daily Dose Trajectories for Episodes of Buprenorphine Treatment for Opioid Use Disorder.
- Development and validation of machine-learning algorithms predicting retention, overdoses, and all-cause mortality among US military veterans treated with buprenorphine for opioid use disorder
- Are gaps in rates of retention on buprenorphine for treatment of opioid use disorder closing among veterans across different races and ethnicities? A retrospective cohort study
Allen M. Smith
University of Arkansas for Medical Sciences
4 shared publications
In database
- Associations Between Early Chiropractic Care and Physical Therapy on Subsequent Opioid Use Among Persons With Low Back Pain in Arkansas
- An updated view on the influence of initial opioid prescription characteristics on long-term opioid use among opioid naïve patients
- Evaluating the temporal association between the recency of prescribed controlled substance acquisition and fatal and non-fatal opioid overdose
- The role of prescribed controlled substance acquisition as potential triggers of opioid overdose: A case-crossover study
Mrinmayee Lakkad
University of Arkansas for Medical Sciences (US)
4 shared publications
- The use of gabapentinoids and opioids and risk of developing opioid-induced respiratory depression among older breast cancer survivors with neuropathic pain
- Factors Associated With Guideline-Concordant Pharmacological Treatment for Neuropathic Pain Among Breast Cancer Survivors
- Healthcare costs and utilization associated with pain among breast cancer survivors: a propensity score matched cohort study using SEER-Medicare data
- Breast Cancer Survivor Risk of Respiratory Depression Associated with Gabapentin and Opioids
Sarah Harrington
Winthrop Rockefeller Foundation (US)
4 shared publications
- The use of gabapentinoids and opioids and risk of developing opioid-induced respiratory depression among older breast cancer survivors with neuropathic pain
- Factors Associated With Guideline-Concordant Pharmacological Treatment for Neuropathic Pain Among Breast Cancer Survivors
- Healthcare costs and utilization associated with pain among breast cancer survivors: a propensity score matched cohort study using SEER-Medicare data
- Breast Cancer Survivor Risk of Respiratory Depression Associated with Gabapentin and Opioids
Ashlynn Fuccello
University of Arkansas for Medical Sciences
4 shared publications
In database
- Clinical outcomes of extended venous thromboembolism prophylaxis after oncologic colorectal surgery
- Disparities in Extended Venous Thromboembolism Prophylaxis After Pancreatic Cancer Surgery
- Venous thromboembolism diagnosis definition in claims data: implications for research
- 80 Venous thromboembolism diagnosis definition in claims data: implications for research
Similar Researchers
Based on overlapping research topics
Carrie Hyde
University of Arkansas for Medical Sciences
Pain Management and Opioid Use
Health disparities and outcomes
Retrospective Studies
Jacob T. Painter
University of Arkansas for Medical Sciences
Pain Management and Opioid Use
Substance Abuse Treatment and Outcomes
Health disparities and outcomes
Ambrish A. Pandit
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Health disparities and outcomes
Retrospective Studies
Mance E. Buttram
University of Arkansas at Fayetteville
Pain Management and Opioid Use
Substance Abuse Treatment and Outcomes
Health disparities and outcomes
A Pandit
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Health disparities and outcomes
Public Health Research
Suzette Lopez
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Health disparities and outcomes
Public Health Research